Glad and terrified: On the ethics of BRCA1 and 2 testing

Cancer Investigation

Volumn 14, Issue 4, 1996, Pages 405-411

  Parens, Erik ^a  

^a HASTINGS CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER TEST; EMPLOYMENT; GENETIC COUNSELING; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEALTH INSURANCE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0029936202     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609012169     Document Type: Review

References (32)

1. Roberts L: Genetic counseling: A preview of what's in store, Science 259:624, 1993.
2. Struewing JP, Abeliovich D, Peretz T, et al: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 11:198-200, 1995.
3. Marshall E: Search for a killer: Focus shifts from fat to hormones. Science 259:618-621, 1993.
4. The Jacobs Institute of Women's Health. Horton JA, ed: The Women's Health Data Book, 2nd ed, Washington, DC, Elsevier, 1995.
5. It is thought that BRCA2 accounts for most of the remaining 50% of germ-line mutations. A little more precisely, it is thought that BRCA1 and BRCA2 account for about 90 - not 100 - percent of heritable breast cancers. See Ezzell C: Breast cancer genes: Cloning BRCA1, mapping BRCA2. J NIH Res 6:33-35, 1994; Marx J: A second breast cancer susceptibility gene is found. Science 271:30-31, 1996.
6. It is thought that BRCA2 accounts for most of the remaining 50% of germ-line mutations. A little more precisely, it is thought that BRCA1 and BRCA2 account for about 90 - not 100 - percent of heritable breast cancers. See Ezzell C: Breast cancer genes: Cloning BRCA1, mapping BRCA2. J NIH Res 6:33-35, 1994; Marx J: A second breast cancer susceptibility gene is found. Science 271:30-31, 1996.
7. Chen Y, Chen C-F, Riley DJ, et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270:789-791, 1995.
8. Miki Y, Swenson J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994.
9. Committee on Assessing Genetic Risks. Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG, eds: Assessing Genetic Risks: Implications for Health and Social Policy, Washington DC, National Academy Press, 1994.
10. King M-C: Inherited breast and ovarian cancer: What are the risks? What are the choices? JAMA 269:1975-1980, 1993.
11. Proctor RN: Cancer Wars: How Politics Shapes What We Know and Don't Know about Cancer, New York, Basic Books, 1995.
12. Wexler NS: The Tiresias complex: Huntington's disease as a paradigm of testing for late-onset disorders. FASEB J 6:2820-2825, 1992.
13. Wilfond BS, Nolan K: National policy development for the clinical application of genetic diagnostic technologies: Lessons from cystic fibrosis. JAMA 270:2948-2954, 1993.
14. Lappe M, Gustafson JM, Roblin R: Ethical and social issues in screening for genetic disease. N Engl J Med 286:1129-1132, 1972.
15. Committee on Inborn Errors of Metabolism: Genetic Screening: Programs, Principles, and Research, Washington, DC, National Academy of Sciences, 1975.
16. Screening and Counseling for Genetic Conditions: The Ethical, Social, and Legal Implications of Genetic Screening, Counseling and Education Programs, Washington, DC, President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983.
17. Schneider KA: Counseling about Cancer: Strategies for Genetic Counselors, Boston, MA, Dana-Farber Cancer Institute, 1994.
18. In addition to Schneider, see Shattuck-Eidens D, McClure M, Simard J, et al: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. JAMA 273:535-541, 1995; Hoskins KF, Stopfer JE, Calzone KA, et al: Assessment and counseling for women with a family history of breast cancer. JAMA 273:577-585, 1995; Lerman C, Croyle R: Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 154:609-616, 1994.
19. In addition to Schneider, see Shattuck-Eidens D, McClure M, Simard J, et al: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. JAMA 273:535-541, 1995; Hoskins KF, Stopfer JE, Calzone KA, et al: Assessment and counseling for women with a family history of breast cancer. JAMA 273:577-585, 1995; Lerman C, Croyle R: Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 154:609-616, 1994.
20. In addition to Schneider, see Shattuck-Eidens D, McClure M, Simard J, et al: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. JAMA 273:535-541, 1995; Hoskins KF, Stopfer JE, Calzone KA, et al: Assessment and counseling for women with a family history of breast cancer. JAMA 273:577-585, 1995; Lerman C, Croyle R: Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 154:609-616, 1994.
21. Caplan A: Neutrality is not morality: The ethics of genetic counseling. In: Prescribing Our Future: Ethical Challenges in Genetic Counseling, edited by DM Bartels, B LeRoy, AL Caplan, New York, De Gruyter, 1993.
22. Wertz DC, Fanos JH, Reilly PR: Genetic testing for childen and adolescents: Who decides? JAMA 272:875-881, 1994.
23. Biesecker BB, Boehnke M, Calzone K, et al: Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 269:1970-1980, 1993.
24. Kolata G: Findings don't account for Long Island's high cancer rate. New York Times, September 29, 1995.
25. Leary WE: Using gene tests to deny jobs is ruled illegal. New York Times, April 8, 1995.
26. Billings PR, Kohn MA, de Cuevas M, et al: Discrimination as a consequence of genetic testing. Am J Hum Genet 50:476-482, 1992; Hudson KL, Rothenberg KH, Andrews LB, et al: Genetic discrimination: An urgent need for reform. Science 270:391-393, 1995.
27. Billings PR, Kohn MA, de Cuevas M, et al: Discrimination as a consequence of genetic testing. Am J Hum Genet 50:476-482, 1992; Hudson KL, Rothenberg KH, Andrews LB, et al: Genetic discrimination: An urgent need for reform. Science 270:391-393, 1995.
28. Paul DB, Spencer HG: The hidden science of eugenics. Nature 374:302-304, 1995.
29. Kolata G: Tests to assess risks for cancer raising questions. New York Times, March 27, 1995.
30. Horton R: Debate on genetic testing for cancer in USA. Lancet 345:848, 1995.
31. National Advisory Council for Human Genome Research: Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA 271:785, 1994.
32. Hoskins KF, Stopfer JE, Calzone KA, et al: Assessment and counseling for women with a family risk of breast cancer JAMA 273:577-585, 1995.